Exploration of the Optimal Treatment Modality for Vitreoretinal Lymphoma: A PRISMA Compliant Meta‐Analysis and Systematic Review
ABSTRACT Background Vitreoretinal lymphoma (VRL) is regarded as a subtype of primary central nervous system lymphoma (PCNSL). Hence, extending progression‐free survival (PFS) is crucial for enhancing the prognosis of VRL patients. Nevertheless, a lack of standard treatment options currently exists f...
Saved in:
| Main Authors: | Jing Gao, Li‐wei Lv, Jing Yang, He‐nan Wang, Liang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.71092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular diagnosis of vitreoretinal lymphoma
by: Jay Jiyong Kwak, et al.
Published: (2025-04-01) -
Clinical guidelines for the diagnosis and treatment of vitreoretinal lymphoma in Chinese patients (2024)
by: Xiao Zhang, et al.
Published: (2025-05-01) -
Assistance of Artificial Intelligence in Diagnosis of Vitreoretinal Lymphoma on Optical Coherence Tomography
by: Aidi Lin, et al.
Published: (2025-04-01) -
A glaucoma drainage implant functioning as a sanctuary site for vitreoretinal lymphoma
by: Debora H. Lee, et al.
Published: (2025-06-01) -
Oral, not gut microbiota diversity, reflects the inflammation and neoplasia in patients with uveitis and vitreoretinal lymphoma
by: Michaela Brichova, et al.
Published: (2025-08-01)